Literature DB >> 9802265

Management of corticosteroid-induced osteoporosis.

J C Stevenson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9802265     DOI： 10.1016/s0140-6736(05)60740-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Bone loss and glucocorticoid therapy in patients with respiratory disease.

Authors:  A Fairney
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe.

Authors:  S R Hart; B Green
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

3.  Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.

Authors:  Robert S Weinstein; Robert L Jilka; Maria Almeida; Paula K Roberson; Stavros C Manolagas
Journal:  Endocrinology       Date:  2010-04-21       Impact factor: 4.736

4.  Prevention of dementia: Role of vascular risk factors and cerebral emboli.

Authors:  Nitin Purandare
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.